Prices delayed by at least 15 minutes | Print
Champions Oncology (CSBR)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.
Address
One University Plaza
Suite 307
Hackensack
NJ
USA
07601
Telephone
+1 646 5367331
Forecast key dates
| Name | Key Date |
|---|---|
| Champions Oncology Inc Third Quarter Earnings Conference Call for 2025 | 2025-03-12T16:30:00 |
| Champions Oncology Inc Third Quarter Earnings Results for 2025 | 2025-03-12T00:00:00 |
| Champions Oncology Inc Second Quarter Earnings Conference Call for 2025 | 2024-12-12T16:30:00 |
| Champions Oncology Inc Second Quarter Earnings Results for 2025 | 2024-12-12T00:00:00 |
| Champions Oncology Inc Annual General Meeting for 2024 | 2024-10-18T09:00:00 |
| Champions Oncology Inc First Quarter Earnings Conference Call for 2025 | 2024-09-13T16:30:00 |
| Champions Oncology Inc First Quarter Earnings Results for 2025 | 2024-09-13T00:00:00 |
| Champions Oncology Inc Fourth Quarter Earnings Conference Call for 2024 | 2024-07-24T16:30:00 |
| Champions Oncology Inc Fourth Quarter Earnings Results for 2024 | 2024-07-24T00:00:00 |
| Champions Oncology Inc Annual Report for 2024 | 2024-07-24T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Champions Oncology Inc Third Quarter Earnings Conference Call for 2024 | 2024-03-12T16:30:00 |
| Champions Oncology Inc Third Quarter Earnings Result for 2024 | 2024-03-12T00:00:00 |
| Champions Oncology Inc Second Quarter Earnings Conference Call for 2024 | 2023-12-12T16:30:00 |
| Champions Oncology Inc Second Quarter Earnings Result for 2024 | 2023-12-12T00:00:00 |
| Champions Oncology Inc Annual General Meeting for 2023 | 2023-10-19T09:00:00 |
| Champions Oncology Inc First Quarter Earnings Conference Call for 2024 | 2023-09-13T16:30:00 |
| Champions Oncology Inc First Quarter Earnings Result for 2024 | 2023-09-13T00:00:00 |
| Champions Oncology Inc Fourth Quarter Earnings Conference Call for 2023 | 2023-07-24T16:30:00 |
| Champions Oncology Inc Fourth Quarter Earnings Result for 2023 | 2023-07-24T00:00:00 |
| Champions Oncology Inc Annual Report for 2023 | 2023-07-24T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.